Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
about
Mesoporous silica nanoparticles in target drug delivery system: A reviewBiocompatibility assessment of Si-based nano- and micro-particlesVEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system.Immobilization of Zidovudine Derivatives on the SBA-15 Mesoporous Silica and Evaluation of Their Cytotoxic Activity.SBA-15 Mesoporous Silica Modified with Gallic Acid and Evaluation of Its Cytotoxic Activity.Silica-based mesoporous nanoparticles for controlled drug delivery.Mesoporous silica nanoparticles functionalized with folic acid/methionine for active targeted delivery of docetaxel.Utilization of Enzyme-Immobilized Mesoporous Silica Nanocontainers (IBN-4) in Prodrug-Activated Cancer Theranostics.Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy.Smart multifunctional drug delivery towards anticancer therapy harmonized in mesoporous nanoparticles.Synthesis of mesoporous-silica-coated Gd2O3:Eu@silica particles as cell imaging and drug delivery agents.Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes.pH-Responsive Isoniazid-Loaded Nanoparticles Markedly Improve Tuberculosis Treatment in MiceSmart surface-enhanced Raman scattering traceable drug delivery systems.Folic acid-conjugated mesoporous silica particles as nanocarriers of natural prodrugs for cancer targeting and antioxidant action.Mesoporous silicananoparticles for the design of smart delivery nanodevicesAcute Oral Toxicity and Kinetic Behaviors of Inorganic Layered Nanoparticles
P2860
Q26799990-BBBBB817-204F-4A22-AD21-5AC91F74CF60Q28389467-A4ADFD92-6F0D-424F-83C3-89E4B8E0F592Q34674541-6BC17A35-CB64-4008-935A-B8D6CCA2FE7EQ35571174-39E3A9A6-E320-42D9-9320-9A2283D4BA3FQ35685323-AB7409BF-B1CB-4288-B9B8-2EABC26D8704Q37151406-6AA4028E-B790-4AD7-A446-214D17C44C54Q37485314-D127F2D1-1C21-49C5-AB57-779D5602624EQ37638585-42B65900-50F3-4834-80C5-9E1754D781E9Q38542764-D8D4C8B9-7CFD-41E9-8B7C-3C82F034BA16Q38563960-D969F1D3-5895-4C90-B91B-8A95143E5EF1Q38886588-C81455B2-B9BB-4B6A-A283-407D914DD0BFQ39928716-2D23B86B-21F6-4447-BC3D-D3A66BF9D2DDQ41099486-95251365-470D-4F5B-84CD-5134636D6BE1Q48610846-C71582AD-EAB8-4E09-80E5-3AE03CFEC7F2Q55237274-94B6481D-4D66-4519-B517-36D3DE21EE32Q57364103-C607B080-342C-46A1-9F47-B6F420EA25FAQ59017206-AB46016E-7771-47BB-BC0D-443416A089B8
P2860
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
@ast
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
@en
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
@nl
type
label
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
@ast
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
@en
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
@nl
prefLabel
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
@ast
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
@en
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
@nl
P2093
P356
P1433
P1476
Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
@en
P2093
Jianquan Fan
Shuizhu Wu
Xiaodan Wang
Yufei Xiang
P304
P356
10.1088/0957-4484/22/45/455102
P577
2011-10-21T00:00:00Z